Wednesday, January 27, 2021  | 12 Jamadilakhir, 1442
Samaa TV
Facebook Twitter Youtube
HOME > Health

Lahore gets 2,000 tests per day BSL-3 lab

This is Punjab's fourth lab

SAMAA | - Posted: Apr 6, 2020 | Last Updated: 10 months ago
Posted: Apr 6, 2020 | Last Updated: 10 months ago
Lahore gets 2,000 tests per day BSL-3 lab

Punjab Chief Minister Usman Buzdar inaugurated the fourth BSL-3 lab of Punjab in Lahore on Monday.

The lab will have a testing capacity of 2,000 tests per day. The chief minister inspected the lab wearing a protective body suit.

The lab had been upgraded to Biological Safety Level 3 last week. The BSL-3 lab is a containment laboratory designed for work with Risk Group 2 and 3 of microorganisms that pose an increased risk of aerosol spread, according to the WHO.

The Punjab government says nine more labs are being upgraded across the province in Bahawalpur, DG Khan, Multan, Lahore, Rawalpindi, Faisalabad, Gujranwala, Kharian and Gujrat.

The number of COVID-19 cases in Punjab has reached 1,493, Buzdar said Monday morning. There are currently 842 patients in quarantine, of whom 309 are pilgrims from Iran and 484 are from the Tablighi Jamaat.

Forty-nine prisoners have also contracted COVID-19 at Camp Jail. The remaining 651 cases are in 28 districts of the province, said Buzdar.

FaceBook WhatsApp

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp

coronavirus vaccine pakistan news today, coronavirus vaccine trials in pakistan, bcg vaccine pakistan coronavirus, astrazeneca covid vaccine approval, astrazeneca vaccine update, astrazeneca vaccine approval, astrazeneca covid vaccine efficacy, astrazeneca vaccine type, astrazeneca vaccine vs pfizer, astrazeneca vaccine usa, astrazeneca vaccine india, oxford university-astrazeneca covid-19 vaccine status, sinopharm vs pfizer, sinovac vaccine efficacy, sinovac vs pfizer vaccine

Bengali ‘Pakistanis’ bring home Russian gold
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp